Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841925
What this trial is testing

BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Post-approval studies (Phase 4)Study completedNCT01932125
What this trial is testing

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Study completedNCT00096525
What this trial is testing

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00934440
What this trial is testing

Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 11
Not applicableStudy completedNCT03323489
What this trial is testing

Celiac Plexus Radio-Surgery for Pain Management

Who this might be right for
Advanced CancerPancreas CancerPain
Dr. Yaacov Lawrence 125
Testing effectiveness (Phase 2)Study completedNCT04089189
What this trial is testing

Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer

Who this might be right for
Ovarian Cancer
Impact Therapeutics, Inc. 93
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Not applicableUnknownNCT02618850
What this trial is testing

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 260
Very early researchUnknownNCT05707325
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies

Who this might be right for
CancerSolid TumorHematologic Malignancy
Westlake Therapeutics 30
Early research (Phase 1)Study completedNCT01497925
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer

Who this might be right for
Solid TumorsProstate Cancer
Polaris Group 43
Not applicableStudy completedNCT01993550
What this trial is testing

Telephone Support Program for Lung Cancer Patients and Their Family Caregivers

Who this might be right for
Lung Cancer
Indiana University 262
Testing effectiveness (Phase 2)Ended earlyNCT00359450
What this trial is testing

Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb 186
Not applicableEnded earlyNCT03993210
What this trial is testing

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Who this might be right for
Gynecologic Tumor
Dana-Farber Cancer Institute 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Not applicableNot Yet RecruitingNCT07035860
What this trial is testing

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Carbon Ion Radiotheray
Ji Yongling 34
Early research (Phase 1)Study completedNCT01863108
What this trial is testing

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Who this might be right for
MelanomaTumor VaccinesEffects of Immunotherapy
University Hospital, Grenoble 9
Large-scale testing (Phase 3)Study completedNCT01414608
What this trial is testing

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+5 more
GOG Foundation 926
Large-scale testing (Phase 3)Looking for participantsNCT06793917
What this trial is testing

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 269
Early research (Phase 1)Study completedNCT02988440
What this trial is testing

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00700440
What this trial is testing

Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 100
Next Page